Journey Medical DERM
NASDAQ DERM
$6.72 -0.12 (-1.75%)
At close: Oct 1, 2026 · 4:00 PM EDT

Journey Medical (DERM) Non Operating Interest Expenses (2020 - 2026)

Updated

Journey Medical's Non Operating Interest Expenses came in at $906,000 for Q2 2026, down 3.3% from $937,000 a year earlier but up 1.6% from the prior quarter.

Analysis

Journey Medical (DERM) Non Operating Interest Expenses (2020 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Journey Medical reported Non Operating Interest Expenses of $3.67 million, up 7.3% year-over-year; for FY2025, it came in at $3.7 million, up 37.0% from FY2024.

  • Non Operating Interest Expenses carries a five-year compound annual growth rate of 39.6% (FY2020 to FY2025).
  • Going back by year, Non Operating Interest Expenses was $2.7 million in FY2024 (+59.0%), $1.7 million in FY2023 (-15.9%), $2.02 million in FY2022 (-71.3%) and $7.03 million in FY2021 (+907.7%).
  • The five-year range for quarterly Non Operating Interest Expenses is $24,000 (Q4 2023) to $4.1 million (Q4 2021).
  • Year-over-year, Non Operating Interest Expenses increased in six of the last seven quarters, with growth averaging 49.2%.
  • The fastest year-over-year change in Non Operating Interest Expenses over five years came in Q3 2021 (growth of 634.2%), and the weakest in Q4 2023 (a decline of 96.1%).
  • Business Quant data shows DERM's Non Operating Interest Expenses at $892,000 (Q1 2026), $933,000 (Q4 2025) and $937,000 (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Operating Interest Expenses (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 281.00 Mn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -462.00 Mn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -435.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 673.00 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 247.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Journey Medical 188.06 Mn 86.15 Mn 12.37 Mn 906,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 906,000.00
Mar 31, 2026 892,000.00
Dec 31, 2025 933,000.00
Sep 30, 2025 937,000.00
Jun 30, 2025 937,000.00
Mar 31, 2025 891,000.00
Dec 31, 2024 831,000.00
Sep 30, 2024 758,000.00
Jun 30, 2024 563,000.00
Mar 31, 2024 548,000.00
Dec 31, 2023 24,000.00
Sep 30, 2023 268,000.00
Jun 30, 2023 756,000.00
Mar 31, 2023 650,000.00
Dec 31, 2022 617,000.00
Sep 30, 2022 559,000.00
Jun 30, 2022 454,000.00
Mar 31, 2022 389,000.00
Dec 31, 2021 4.10 Mn
Sep 30, 2021 1.37 Mn
API Access

Journey Medical Non Operating Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=DERM&period=max&api_key=YOUR_API_KEY